| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| 1-150x150.png | 2024-03-06 03:01 | 19K | ||
| 1-300x169.png | 2024-03-06 03:01 | 37K | ||
| 1-768x432.png | 2024-03-06 03:01 | 176K | ||
| 1-1024x576.png | 2024-03-06 03:01 | 284K | ||
| 1-1536x864.png | 2024-03-06 03:01 | 547K | ||
| 1.png | 2024-03-06 03:01 | 754K | ||
| 2-150x150.png | 2024-03-06 03:01 | 17K | ||
| 2-300x169.png | 2024-03-06 03:01 | 34K | ||
| 2-768x432.png | 2024-03-06 03:01 | 145K | ||
| 2-1024x576.png | 2024-03-06 03:01 | 227K | ||
| 2-1536x864.png | 2024-03-06 03:01 | 414K | ||
| 2.png | 2024-03-06 03:01 | 530K | ||
| 3-150x150.png | 2024-03-06 03:01 | 17K | ||
| 3-300x169.png | 2024-03-06 03:01 | 32K | ||
| 3-768x432.png | 2024-03-06 03:01 | 137K | ||
| 3-1024x576.png | 2024-03-06 03:01 | 221K | ||
| 3-1536x864.png | 2024-03-06 03:01 | 430K | ||
| 3.png | 2024-03-06 03:01 | 623K | ||
| 4-150x150.png | 2024-03-06 03:01 | 17K | ||
| 4-300x169.png | 2024-03-06 03:01 | 32K | ||
| 4-768x432.png | 2024-03-06 03:01 | 132K | ||
| 4-1024x576.png | 2024-03-06 03:01 | 205K | ||
| 4-1536x864.png | 2024-03-06 03:01 | 366K | ||
| 4.png | 2024-03-06 03:01 | 462K | ||
| 5-150x150.png | 2024-03-06 03:01 | 18K | ||
| 5-300x169.png | 2024-03-06 03:01 | 34K | ||
| 5-768x432.png | 2024-03-06 03:01 | 146K | ||
| 5-1024x576.png | 2024-03-06 03:01 | 226K | ||
| 5-1536x864.png | 2024-03-06 03:01 | 405K | ||
| 5.png | 2024-03-06 03:01 | 510K | ||
| 6-150x150.png | 2024-03-06 03:01 | 17K | ||
| 6-300x169.png | 2024-03-06 03:01 | 30K | ||
| 6-768x432.png | 2024-03-06 03:01 | 128K | ||
| 6-1024x576.png | 2024-03-06 03:01 | 199K | ||
| 6-1536x864.png | 2024-03-06 03:01 | 367K | ||
| 6.png | 2024-03-06 03:01 | 487K | ||
| 2024list_en_final_22..> | 2024-03-28 07:25 | 10K | ||
| 2024list_en_final_22..> | 2024-03-28 07:25 | 16K | ||
| 2024list_en_final_22..> | 2024-03-28 07:25 | 81K | ||
| 2024list_en_final_22..> | 2024-03-28 07:25 | 152K | ||
| 2024list_en_final_22..> | 2024-03-28 07:25 | 371K | ||
| 200701-WWR-Antidopin..> | 2024-03-08 05:19 | 300K | ||
| 200701-WWR-Antidopin..> | 2024-03-08 05:19 | 5.8K | ||
| 200701-WWR-Antidopin..> | 2024-03-08 05:19 | 8.0K | ||
| 200701-WWR-Antidopin..> | 2024-03-08 05:19 | 24K | ||
| 200701-WWR-Antidopin..> | 2024-03-08 05:19 | 40K | ||
| 20240301-WWR-Interna..> | 2024-03-01 03:02 | 6.7K | ||
| 20240301-WWR-Interna..> | 2024-03-01 03:02 | 11K | ||
| 20240301-WWR-Interna..> | 2024-03-01 03:02 | 40K | ||
| 20240301-WWR-Interna..> | 2024-03-01 03:02 | 66K | ||
| 20240301-WWR-Interna..> | 2024-03-01 03:02 | 1.5M | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 4.1K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 8.2K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 37K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 66K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 2.4M | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 6.9K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 11K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 39K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 69K | ||
| 20240301-Wheelchair-..> | 2024-03-01 03:02 | 1.1M | ||
| 20240307-WWR-Antidop..> | 2024-03-08 05:17 | 5.8K | ||
| 20240307-WWR-Antidop..> | 2024-03-08 05:17 | 8.2K | ||
| 20240307-WWR-Antidop..> | 2024-03-08 05:17 | 24K | ||
| 20240307-WWR-Antidop..> | 2024-03-08 05:17 | 41K | ||
| 20240307-WWR-Antidop..> | 2024-03-08 05:17 | 430K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 40K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 51K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 120K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 171K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 296K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 451K | ||
| 20240318_WWRPQT_384-..> | 2024-03-18 13:18 | 632K | ||
| 20240318_WWRPQT_384.jpg | 2024-03-18 13:17 | 2.5M | ||
| 20240326-Additional-..> | 2024-03-28 07:14 | 5.9K | ||
| 20240326-Additional-..> | 2024-03-28 07:14 | 8.5K | ||
| 20240326-Additional-..> | 2024-03-28 07:14 | 27K | ||
| 20240326-Additional-..> | 2024-03-28 07:14 | 46K | ||
| 20240326-Additional-..> | 2024-03-28 07:14 | 90K | ||
| 20240326-Antidoping-..> | 2024-03-28 07:14 | 5.7K | ||
| 20240326-Antidoping-..> | 2024-03-28 07:14 | 8.1K | ||
| 20240326-Antidoping-..> | 2024-03-28 07:14 | 25K | ||
| 20240326-Antidoping-..> | 2024-03-28 07:14 | 44K | ||
| 20240326-Antidoping-..> | 2024-03-28 07:14 | 150K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 5.2K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 9.9K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 39K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 61K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 117K | ||
| 432853355_1016358819..> | 2024-03-28 08:00 | 382K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 6.1K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 14K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 55K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 85K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 161K | ||
| 434089141_1016358790..> | 2024-03-28 08:00 | 475K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 8.4K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 27K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 120K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 186K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 8.8K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 20K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 92K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 143K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 171K | ||
| 434182268_1834573666..> | 2024-03-28 07:53 | 340K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 7.1K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 14K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 56K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 86K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 161K | ||
| 434234689_1016359004..> | 2024-03-28 08:00 | 476K | ||
| WWR-TUE-Application-..> | 2024-03-08 05:20 | 5.7K | ||
| WWR-TUE-Application-..> | 2024-03-08 05:20 | 8.0K | ||
| WWR-TUE-Application-..> | 2024-03-08 05:20 | 23K | ||
| WWR-TUE-Application-..> | 2024-03-08 05:20 | 38K | ||
| WWR-TUE-Application...> | 2024-03-08 05:19 | 172K | ||
| WWR-TUE-Application.pdf | 2024-03-08 05:20 | 194K | ||
| WWR-Therapeutic-Exem..> | 2024-03-08 05:14 | 5.8K | ||
| WWR-Therapeutic-Exem..> | 2024-03-08 05:14 | 8.4K | ||
| WWR-Therapeutic-Exem..> | 2024-03-08 05:14 | 26K | ||
| WWR-Therapeutic-Exem..> | 2024-03-08 05:14 | 44K | ||
| WWR-Therapeutic-Exem..> | 2024-03-08 05:14 | 272K | ||
